Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Henagliflozin and Metformin interaction study
NCT02354027Phase 1Completed
- Sponsor
- Hengrui
- Start
- Sep 2014
- Primary completion
- Nov 2014
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of henagliflozin in type 2 diabetes mellitus (T2DM), sponsored by Hengrui. Primary endpoints: Maximum Plasma Concentration of SHR3824 at Day 9, Area Under the Plasma Concentration-Time Curve of SHR3824 at Day 9 and 2 more. Started Sep 2014; status: completed.
02
Drugs
henagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02354027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02354027.